I am a senior life sciences leader with experience across diagnostic pathology and pharmaceutical R&D, currently working in laboratory operations and diagnostic deployment for global oncology trials. I help organisations turn diagnostic innovation into scalable, compliant services.
My expertise covers biomarker and companion diagnostic strategy, IHC and molecular pathology, assay validation and transfer, digital pathology and AI, and diagnostic and clinical-trial laboratory operations.
I have led multidisciplinary services, automation, performance improvement, capital investment cases and complex transformation programmes, with practical experience of ISO15289, CAP/CLIA, GCP and risk-based design controls.
I advise on technology selection, laboratory operating models, quality and regulatory readiness, partner oversight and commercial scalability. I combine a laboratory medicine background and an MBA with a track record of delivering change in highly regulated environments.